SEC Form 4 · accession 0001013606-16-000277
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dan Lemaitre
Director
Period of report
Jun 2, 2016
Accepted (ET)
Jun 3, 2016 · 3:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 2, 2016 | A | 11,485 | $0.00 | A | 46,167 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Time based restricted stock unit award vesting over 1 year.